| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.
|
N Engl J Med
|
1998
|
53.26
|
|
2
|
Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions.
|
N Engl J Med
|
2007
|
15.40
|
|
3
|
A review of human carcinogens--Part B: biological agents.
|
Lancet Oncol
|
2009
|
13.85
|
|
4
|
Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases.
|
N Engl J Med
|
2007
|
12.17
|
|
5
|
Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males.
|
N Engl J Med
|
2011
|
11.09
|
|
6
|
Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial.
|
Lancet Oncol
|
2005
|
9.67
|
|
7
|
Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003.
|
Ann Intern Med
|
2008
|
7.71
|
|
8
|
Chapter 2: The burden of HPV-related cancers.
|
Vaccine
|
2006
|
7.70
|
|
9
|
Survival of persons with and without HIV infection in Denmark, 1995-2005.
|
Ann Intern Med
|
2007
|
6.30
|
|
10
|
Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study.
|
Lancet Oncol
|
2008
|
6.20
|
|
11
|
Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis.
|
Lancet Oncol
|
2012
|
6.05
|
|
12
|
HPV vaccine against anal HPV infection and anal intraepithelial neoplasia.
|
N Engl J Med
|
2011
|
4.69
|
|
13
|
Recommendations on the use of quadrivalent human papillomavirus vaccine in males--Advisory Committee on Immunization Practices (ACIP), 2011.
|
MMWR Morb Mortal Wkly Rep
|
2011
|
4.68
|
|
14
|
Natural history of cervical intraepithelial neoplasia: a critical review.
|
Int J Gynecol Pathol
|
1993
|
4.67
|
|
15
|
The epidemiology of genital human papillomavirus infection.
|
Vaccine
|
2006
|
3.28
|
|
16
|
HIV infection and the risk of cancers with and without a known infectious cause.
|
AIDS
|
2009
|
3.13
|
|
17
|
Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions.
|
Int J Cancer
|
2009
|
2.90
|
|
18
|
Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data.
|
BMJ
|
2012
|
2.77
|
|
19
|
Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy.
|
AIDS
|
2008
|
2.74
|
|
20
|
Age-specific prevalence, incidence, and duration of human papillomavirus infections in a cohort of 290 US men.
|
J Infect Dis
|
2008
|
2.56
|
|
21
|
The burden of genital warts: a study of nearly 70,000 women from the general female population in the 4 Nordic countries.
|
J Infect Dis
|
2007
|
2.14
|
|
22
|
Surgical treatment of high-grade anal squamous intraepithelial lesions: a prospective study.
|
Dis Colon Rectum
|
2002
|
1.53
|
|
23
|
Colposcopic appearance of anal squamous intraepithelial lesions: relationship to histopathology.
|
Dis Colon Rectum
|
1997
|
1.52
|
|
24
|
A population-based analysis of temporal trends in the incidence of squamous anal canal cancer in relation to the HIV epidemic.
|
J Acquir Immune Defic Syndr
|
2005
|
1.51
|
|
25
|
Comparison of imiquimod, topical fluorouracil, and electrocautery for the treatment of anal intraepithelial neoplasia in HIV-positive men who have sex with men: an open-label, randomised controlled trial.
|
Lancet Oncol
|
2013
|
1.47
|
|
26
|
Virologic, immunologic, and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual men.
|
J Acquir Immune Defic Syndr Hum Retrovirol
|
1998
|
1.46
|
|
27
|
Cervical screening: a guideline for clinical practice in Ontario.
|
J Obstet Gynaecol Can
|
2012
|
1.43
|
|
28
|
Anal cancers among HIV-infected persons: HAART is not slowing rising incidence.
|
AIDS
|
2010
|
1.39
|
|
29
|
Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in HIV-1-infected men.
|
J Infect Dis
|
2010
|
1.37
|
|
30
|
Malignant progression of anal intra-epithelial neoplasia.
|
ANZ J Surg
|
2006
|
1.28
|
|
31
|
Infrared coagulator: a useful tool for treating anal squamous intraepithelial lesions.
|
Dis Colon Rectum
|
2005
|
1.28
|
|
32
|
Incidence of HIV-related anal cancer remains increased despite long-term combined antiretroviral treatment: results from the french hospital database on HIV.
|
J Clin Oncol
|
2012
|
1.27
|
|
33
|
The role of cytology (Pap tests) and human papillomavirus testing in anal cancer screening.
|
AIDS
|
2010
|
1.25
|
|
34
|
HPV testing in primary cervical screening: a systematic review and meta-analysis.
|
J Obstet Gynaecol Can
|
2012
|
1.25
|
|
35
|
Continuing declines in some but not all HIV-associated cancers in Australia after widespread use of antiretroviral therapy.
|
AIDS
|
2009
|
1.22
|
|
36
|
Malignant transformation of high-grade anal intraepithelial neoplasia.
|
Br J Surg
|
2005
|
1.20
|
|
37
|
Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study.
|
Br J Cancer
|
2002
|
1.20
|
|
38
|
Prevention of recurrent high-grade anal neoplasia with quadrivalent human papillomavirus vaccination of men who have sex with men: a nonconcurrent cohort study.
|
Clin Infect Dis
|
2012
|
1.14
|
|
39
|
Recrudescence of cervical dysplasia among women who are infected with the human immunodeficiency virus: a case-control analysis.
|
Am J Obstet Gynecol
|
2002
|
1.11
|
|
40
|
A study of anal intraepithelial neoplasia in HIV positive homosexual men.
|
Sex Transm Infect
|
1999
|
1.03
|
|
41
|
Infrared coagulator ablation of high-grade anal squamous intraepithelial lesions in HIV-negative males who have sex with males.
|
Dis Colon Rectum
|
2007
|
0.98
|
|
42
|
Breast and cervical cancer surveillance, United States, 1973-1987.
|
MMWR CDC Surveill Summ
|
1992
|
0.95
|
|
43
|
Long-term follow-up of infrared coagulator ablation of anal high-grade dysplasia in men who have sex with men.
|
Dis Colon Rectum
|
2011
|
0.94
|
|
44
|
Long-term outcome of ablation of anal high-grade squamous intraepithelial lesions: recurrence and incidence of cancer.
|
Dis Colon Rectum
|
2014
|
0.93
|
|
45
|
Novel microsphere-based method for detection and typing of 46 mucosal human papillomavirus types.
|
J Clin Microbiol
|
2011
|
0.93
|
|
46
|
Combined modality therapy for HIV-infected patients with squamous cell carcinoma of the anus: outcomes and toxicities.
|
Int J Radiat Oncol Biol Phys
|
2006
|
0.91
|
|
47
|
Electrocautery ablation of high-grade anal squamous intraepithelial lesions in HIV-negative and HIV-positive men who have sex with men.
|
J Acquir Immune Defic Syndr
|
2012
|
0.86
|
|
48
|
Acceptability of human papillomavirus vaccination and sexual experience prior to disclosure to health care providers among men who have sex with men in Vancouver, Canada: implications for targeted vaccination programs.
|
Vaccine
|
2012
|
0.84
|
|
49
|
A comparison of human papillomavirus genotype-specific DNA and E6/E7 mRNA detection to identify anal precancer among HIV-infected men who have sex with men.
|
Cancer Epidemiol Biomarkers Prev
|
2012
|
0.81
|
|
50
|
Anal cancer and screening guidelines for human papillomavirus in men.
|
J Am Osteopath Assoc
|
2011
|
0.80
|
|
51
|
Ten-year results of chemoradiation for anal cancer: focus on late morbidity.
|
Int J Radiat Oncol Biol Phys
|
1996
|
0.78
|